brintellex
ValprolBanner
Annals of Indian Academy of Neurology
  Users Online: 2918 Home | About the Journal | InstructionsCurrent Issue | Back IssuesLogin      Print this page Email this page  Small font size Default font size Increase font size
This article has been cited by
1The future of multiple sclerosis treatments
Catalina Coclitu,Cris S. Constantinescu,Radu Tanasescu
Expert Review of Neurotherapeutics.2016;16(12)1341
[DOI]
2Epigenetic insights into multiple sclerosis disease progression
L. Kular,M. Jagodic
Journal of Internal Medicine.2020;288(1)82
[DOI]
3Zelldepletion und Myeloablation bei neuroimmunologischen Erkrankungen
M. Diebold,L. Kappos,T. Derfuss
Der Nervenarzt.2016;87(8)814
[DOI]
4Initiating disease-modifying treatments in multiple sclerosis: Measuring the decision process using decisional conflict and decisional regret scales
DD Wilkie,A Solari,R Nicholas
Multiple Sclerosis Journal - Experimental, Translational and Clinical.2019;5(1)205521731983300
[DOI]
5Initiating disease-modifying treatments in multiple sclerosis: Measuring the decision process using decisional conflict and decisional regret scales
Angela M. Hill,Jasmine B. R. Cutler,Kristin Robinson
Multiple Sclerosis Journal - Experimental, Translational and Clinical.2019;5(1)767
[DOI]
6FTY720-induced enhancement of autophagy protects cells from FTY720 cytotoxicity in colorectal cancer
JUAN LI,SHU-WEI WANG,DONG-SHENG ZHANG,YE SUN,CHUN-YAN ZHU,QIANG FEI,JUN HU,CHUAN ZHANG,YUE-MING SUN
Oncology Reports.2016;35(5)2833
[DOI]
7Alemtuzumab for Multiple Sclerosis
Mark D. Willis,Neil P. Robertson
Current Neurology and Neuroscience Reports.2016;16(9)2833
[DOI]
8Children with multiple sclerosis should not become therapeutic hostages
Klaus Rose,Thomas Müller
Therapeutic Advances in Neurological Disorders.2016;9(5)389
[DOI]
9Children with multiple sclerosis should not become therapeutic hostages
Anne Vehlow,Katja Storch,Daniela Matzke,Nils Cordes
Therapeutic Advances in Neurological Disorders.2016;198(5)89
[DOI]
10Familieplanlegging, graviditet og amming ved multippel sklerose
Trygve Holmøy,Øivind Torkildsen
Tidsskrift for Den norske legeforening.2016;136(20)1726
[DOI]
  About this journal 
  Editorial Board 
  Online Submission 
  Current Issue 
  Archives 
  Ahead of print 
  Instructions to Authors 
  Subscription
  Alerting 
  Feedback 

Submit Articles

Alerts

Join us